---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-072268"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2026-06-26T10:10:17+00:00"
generated_at: "2026-06-26T10:15:21.441378+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences to merge with Noble Africa (Renergen), ASP Isotopes to control combined entity

## Summary
- ENDRA enters merger with Noble Africa LLC; Merger Sub merges into Noble, with Noble surviving as ENDRA sub.
- Concurrent $50M PIPE investment into Noble from ASPI and institutional investors at $6.57/unit.
- Post-merger, ENDRA renamed Noble Africa Inc.; dual-class stock with Class B having 10 votes/share controlled by ASPI.
- Board set at 7 directors: 5 Noble designees, 1 ENDRA designee, CEO; classified board.
- Closing conditions include ENDRA having $3.8M cash, stockholder approval, SEC registration, and DFC consent.

## SEC filing metadata
- accession: 0001213900-26-072268
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2026-06-26T10:10:17+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 5.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000121390026072268/0001213900-26-072268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000121390026072268/ea0295239-8k425_endra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-072268
- JSON: https://secwatch.observer/filing/0001213900-26-072268.json
- Plain text: https://secwatch.observer/filing/0001213900-26-072268.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.